Clinical Trial Update: Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of autologous bone marrow stem cells for chronic kidney disease; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Autologous bone marrow stem cells (autologous bone marrow stem cells)

Snippet

Sponsor: International Stemcell Services Limited | Conditions: Chronic Renal Failure | Phase 1, Phase 2 | Status: UNKNOWN